Observational study to assess compliance, safety issues and treatment response to single pill once daily regimen of Tenofovir, Lamivudine, Efavirenz (TLE) in HIV infected adult patients
- Conditions
- Health Condition 1: null- HIV patients receiving ART
- Registration Number
- CTRI/2016/03/006742
- Lead Sponsor
- Department of Pharmacology IPGMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 150
i.All HIV infected adult patients (age >18 years) of either gender attending and registered to ART centre of SSKM hospital.
ii.HIV infected adult patients being initiated on fixed dose combination TLE regimen or those who are being shifted to fixed dose combination TLE regimen from other ART regimens (e.g. TL+N or ZL+E or ZL+N).
iii.Willing to provide written informed consent.
i.Patients who are on ART regimens other than TLE.
ii.Patients being shifted to TL+E only due to concomitant Anti Tubercular Drug administration
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.